🌍·6d agoResearch
Pembrolizumab in advanced acral lentiginous melanoma: final results of a single-centre, open-label, phase II trial in an East Asian population
Publisher
E
Europe PMC
EU
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Europe PMC
- Region
- EU
- Scope
- Research
- Published
- July 23, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on europepmc.org
Leave the platform to read the original full article on the publisher site.
Source: Europe PMC
Scope: Research
Related coverage
More related coverage
Manchester University NHS Foundation Trust/8h ago
Manchester achieves major milestone in the fight against Hepatitis C
Universitätsspital Zürich (USZ)/9h ago
COPD-Rehabilitation in der Höhe Kirgistans
Universitätsspital Zürich (USZ)/11h ago
Erfolgreiche ESTRO 2026: Starke wissenschaftliche Präsenz und ein besonderer Abschied
University of Minnesota/8h ago